Philipp Haas
Founder of Haas invest4 Innovation Fund, Creator of investresearch
The Fundrise Innovation Fund looks like a greater-fool trade: after rising 1,288% this month it trades at roughly 20x NAV, a 1,500-2,000% premium. Its holdings are weighted toward Anthropic, Databricks, OpenAI, Anduril and SpaceX, so buying it is like paying $34 trillion for SpaceX or $16 trillion for OpenAI. Shorting is impractical given its very low float and lack of options for hedging, but buying in means playing hot potato. x.comÂ
Fundrise Innovation Fund is dangerously overpriced after a 1,100% surge in a week. Buyers are paying about 20 times its value, implying a $5.5 trillion valuation for Anthropic, its 21% holding, while Anthropic trades at $500 billion at best in the secondary market. The frenzy reflects desperation for exposure to private AI leaders that refuse to go public, not the fund's worth, so it should not be chased. x.comÂ
VCX should keep rising during Anthropic's IPO marketing on retail hype, with every update touting the deal as 100x oversubscribed and indicated to open far above its initial range. x.comÂ
Fundrise's private startup ETF trades at 19x NAV, which means paying $19 for something worth $1. Fairer private-market exposure exists: Kraken Robotics supplies $2-8M of components per Anduril subsea drone; EchoStar's SpaceX stake implies about $140 a share of NAV at a $1.75T SpaceX valuation, versus $115; and Stack Capital holds OpenAI, Crusoe, SpaceX, Canva and Shield AI at about 1x NAV. Buyers of the ETF risk becoming exit liquidity in a meme stock. x.com x.comÂ
Fundrise's Innovation Fund is a low-volume pump and dump, so buying it is gambling, not investing. Per @JoshKale, the fund, which holds Anthropic, OpenAI, SpaceX, Databricks and Anduril, has a $19 NAV per share but traded at $312 after a 1,500% jump in five days, valuing a $650 million fund at $5.4 billion. It could go higher, but chasing a stock trading this erratically on around 500K volume is foolish. x.com x.com x.comÂ
Fundrise's VCX fund, which owns Anthropic, OpenAI and SpaceX, could squeeze higher as those private giants keep getting rerated almost every week. Its chart is flagging and getting very tight. x.comÂ
The Fundrise Innovation Fund is not the right way to get venture exposure, even though a venture allocation can benefit long-term investors. A purposefully engineered squeeze on hype-cycle assets just creates more retail bag holders rather than better strategic portfolios. x.comÂ
The Fundrise Innovation Fund looks wildly overpriced, trading at a premium to NAV never seen before. The listed fund offers access to private companies investors want but cannot otherwise own, and its price went parabolic in just four days. x.com x.comÂ
Fundrise Innovation Fund's roughly 30x premium to net asset value makes the long-term math hard to justify. Per @JoshKale, it trades near $565 against about $19 a share in holdings such as Anthropic, OpenAI, SpaceX, Databricks and Anduril, valuing a $650 million portfolio near $10 billion. That is retail demand decoupling from reality among people who feel locked out of private names, and buyers start with a 97% handicap on their capital. x.comÂ
Fundrise Innovation Fund (VCX) is a game of musical chairs, and buyers at today's price deserve to lose money. Per @JoshKale, it holds stakes in Anthropic, OpenAI, SpaceX, Databricks and Anduril, and surged 1,500% in five days, valuing a roughly $650M fund at about $5.4B, an 8x premium paid just to touch these private companies. x.comÂ